Search Results 201-210 of 17523 for vitiligo

  1. Combination Vaccine Immunotherapy (DRibbles) for Patients with Definitively-treated Stage III Non-small Cell Lung Cancer - Mayo Clinic

    Active autoimmune disease except for vitiligo or hypothyroidism; Active other malignancy; Known HIV+ and/or Hepatitis B or C positive; Medical or psychiatric ...

  2. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

    Patients with vitiligo or alopecia;; Patients with hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement;; Any chronic skin ...

  3. Hemangioma - Doctors and departments - Mayo Clinic

    ... Vitiligo, Oral lichen planus, Nonmelanoma skin cancer, Tuberous sclerosis, Klippel-Trenaunay syndrome, Melasma, Alopecia areata, Diffuse capillary ...

  4. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

    Patients with eczema, psoriasis, lichen simplex chronicus, or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis are ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  6. Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery - Mayo Clinic

    Patients with vitiligo, endocrine deficiencies including thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  8. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

    Any unresolved toxicity NCI CTCAE Grade ≥ 2 from previous anticancer therapy; with the exception of vitiligo and alopecia. Participating Mayo Clinic ...

  9. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...

  10. Publications - Nneka I. Comfere, M.D. - Mayo Clinic

    Hypopigmented mycosis fungoides: A clinical mimicker of vitiligo. Journal of Drugs in Dermatology. 2015; 14(2):193-4. View PubMed; Gonzalez Santiago TM ...